Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lucie Karayan

Showing results (61-70 of 69) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 69 results.
Frontiers in Genetics|January 20, 2022
HSP110 as a Diagnostic but Not a Prognostic Biomarker in Colorectal Cancer With Microsatellite InstabilityGaelle Tachon, Arnaud Chong-Si-Tsaon, Thierry Lecomte, et al.
Molecular Cancer|September 9, 2010
An ANOCEF genomic and transcriptomic microarray study of the response to radiotherapy or to alkylating first-line chemotherapy in glioblastoma patientsFrançois Ducray, Aurélien de Reyniès, Olivier Chinot, et al.
European Journal of Cancer (Oxford, England : 1990)|October 26, 2021
Standardisation of pathogenicity classification for somatic alterations in solid tumours and haematologic malignanciesFlorence Koeppel, Etienne Muller, Alexandre Harlé, et al.
Cancer Biomarkers : Section a of Disease Markers|August 12, 2017
Clinical validation of the CE-IVD marked Therascreen MGMT kit in a cohort of glioblastoma patientsVéronique Quillien, Audrey Lavenu, François Ducray, et al.
Oncotarget|August 20, 2016
Validation of the high-performance of pyrosequencing for clinical MGMT testing on a cohort of glioblastoma patients from a prospective dedicated multicentric trialVéronique Quillien, Audrey Lavenu, François Ducray, et al.
Journal of the National Cancer Institute|February 4, 2016
Efficacy of Adjuvant Chemotherapy in Colon Cancer With Microsatellite Instability: A Large Multicenter AGEO StudyDavid Tougeron, Guillaume Mouillet, Isabelle Trouilloud, et al.
International Journal of Molecular Sciences|April 23, 2022
Heterogeneity of Mismatch Repair Status and Microsatellite Instability between Primary Tumour and Metastasis and Its Implications for Immunotherapy in Colorectal CancersCamille Evrard, Stéphane Messina, David Sefrioui, et al.
Oncogene|November 9, 2023
Shallow whole genome sequencing approach to detect Homologous Recombination Deficiency in the PAOLA-1/ENGOT-OV25 phase-III trialCeline Callens, Manuel Rodrigues, Adrien Briaux, et al.
Nature Communications|April 29, 2024
VC-resist glioblastoma cell state: vessel co-option as a key driver of chemoradiation resistanceCathy Pichol-Thievend, Oceane Anezo, Aafrin M Pettiwala, et al.
Pageof 7

Showing results (61-70 of 69) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 69 results.
Frontiers in Genetics|January 20, 2022
HSP110 as a Diagnostic but Not a Prognostic Biomarker in Colorectal Cancer With Microsatellite InstabilityGaelle Tachon, Arnaud Chong-Si-Tsaon, Thierry Lecomte, et al.
Molecular Cancer|September 9, 2010
An ANOCEF genomic and transcriptomic microarray study of the response to radiotherapy or to alkylating first-line chemotherapy in glioblastoma patientsFrançois Ducray, Aurélien de Reyniès, Olivier Chinot, et al.
European Journal of Cancer (Oxford, England : 1990)|October 26, 2021
Standardisation of pathogenicity classification for somatic alterations in solid tumours and haematologic malignanciesFlorence Koeppel, Etienne Muller, Alexandre Harlé, et al.
Cancer Biomarkers : Section a of Disease Markers|August 12, 2017
Clinical validation of the CE-IVD marked Therascreen MGMT kit in a cohort of glioblastoma patientsVéronique Quillien, Audrey Lavenu, François Ducray, et al.
Oncotarget|August 20, 2016
Validation of the high-performance of pyrosequencing for clinical MGMT testing on a cohort of glioblastoma patients from a prospective dedicated multicentric trialVéronique Quillien, Audrey Lavenu, François Ducray, et al.
Journal of the National Cancer Institute|February 4, 2016
Efficacy of Adjuvant Chemotherapy in Colon Cancer With Microsatellite Instability: A Large Multicenter AGEO StudyDavid Tougeron, Guillaume Mouillet, Isabelle Trouilloud, et al.
International Journal of Molecular Sciences|April 23, 2022
Heterogeneity of Mismatch Repair Status and Microsatellite Instability between Primary Tumour and Metastasis and Its Implications for Immunotherapy in Colorectal CancersCamille Evrard, Stéphane Messina, David Sefrioui, et al.
Oncogene|November 9, 2023
Shallow whole genome sequencing approach to detect Homologous Recombination Deficiency in the PAOLA-1/ENGOT-OV25 phase-III trialCeline Callens, Manuel Rodrigues, Adrien Briaux, et al.
Nature Communications|April 29, 2024
VC-resist glioblastoma cell state: vessel co-option as a key driver of chemoradiation resistanceCathy Pichol-Thievend, Oceane Anezo, Aafrin M Pettiwala, et al.
Pageof 7